p.74 抽出テキスト

1165. PMID: 16302897 201. Orlov MV, Gardin JM, Slawsky M, et al. Biventricular pacing improves cardiac function and prevents further left atrial remodeling in patients with symptomatic atrial fibrillation after atrioventricular node ablation. Am Heart J 2010; 159: 264- 270. PMID: 20152225 202. Huang W, Wang S, Su L, et al. His-bundle pacing vs biventricular pacing following atrioventricular nodal ablation in patients with atrial fibrillation and reduced ejection fraction: a multicenter, randomized, crossover study-The ALTERNATIVE-AF trial. Heart Rhythm 2022; 19: 1948-1955. PMID: 35843465 203. Occhetta E, Bortnik M, Magnani A, et al. Prevention of ventricular desynchronization by permanent para-Hisian pacing after atrioventricular node ablation in chronic atrial fibrillation: a crossover, blinded, randomized study versus apical right ventricular pacing. J Am Coll Cardiol 2006; 47: 1938-1945. PMID: 16697308 204. Pillai A, Kolominsky J, Koneru JN, et al. Atrioventricular junction ablation in patients with conduction system pacing leads: a comparison of His-bundle vs left bundle branch area pacing leads. Heart Rhythm 2022; 19: 1116-1123. PMID: 35351624 205. Cazeau S, Ritter P, Bakdach S, et al. Four chamber pacing in dilated cardiomyopathy. Pacing Clin Electrophysiol 1994; 17: 1974-1979. PMID: 7845801 206. Bakker PF, Meijburg HW, de Vries JW, et al. Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function. J Interv Card Electrophysiol 2000; 4: 395-404. PMID: 10936005 207. Cazeau S, Leclercq C, Lavergne T, et al. Multisite Stimulation in Cardiomyopathies (MUSTIC) Study Investigators. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 2001; 344: 873-880. PMID: 11259720 208. Abraham WT, Fisher WG, Smith AL, et al. MIRACLE Study Group. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-1853. PMID: 12063368 209. Leclercq C, Walker S, Linde C, et al. Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J 2002; 23: 1780-1787. PMID: 12419298 210. Auricchio A, Stellbrink C, Sack S, et al. Pacing Therapies in Congestive Heart Failure (PATH-CHF) Study Group. Long-term clinical effect of hemodynamically optimized cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay. J Am Coll Cardiol 2002; 39: 2026-2033. PMID: 12084604 211. Daubert JC, Saxon L, Adamson PB, et al. 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace 2012; 14: 1236-1286. PMID: 22930717 212. Sipahi I, Chou JC, Hyden M, et al. Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Am Heart J 2012; 163: 260-267. PMID: 22305845 213. Varma N, Lappe J, He J, et al. Sex-specific response to cardiac resynchronization therapy: effect of left ventricular size and QRS duration in left bundle branch block. JACC Clin Electrophysiol 2017; 3: 844-853. PMID: 29759781 214. Varma N, Sogaard P, Bax JJ, et al. Interaction of left ventricular size and sex on outcome of cardiac resynchronization therapy among patients with a narrow QRS duration in the EchoCRT trial. J Am Heart Assoc 2018; 7: e009592. PMID: 29807890 215. Linde C, Cleland JGF, Gold MR, et al. The interaction of sex, height, and QRS duration on the effects of cardiac resynchronization therapy on morbidity and mortality: an individual-patient data meta-analysis. Eur J Heart Fail 2018; 20: 780- 791. PMID: 29314424 216. Zweerink A, Friedman DJ, Klem I, et al. Size matters: normalization of QRS duration to left ventricular dimension improves prediction of long-term cardiac resynchronization therapy outcome. Circ Arrhythm Electrophysiol 2018; 11: e006767. PMID: 30541355 217. Varma N, Wang JA, Jaswal A, et al. CRT efficacy in “Mid-Range” QRS duration among Asians contrasted to non-Asians, and influence of height. JACC Clin Electrophysiol 2022; 8: 211- 221. PMID: 34838518 218. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/ HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145: e895-e1032. PMID: 35363499 219. Ezekowitz JA, O’Meara E, McDonald MA, et al. 2017 Comprehen- sive update of the Canadian Cardiovascular Society guidelines for the management of heart failure. Can J Cardiol 2017; 33: 1342- 1433. PMID: 29111106 220. Yu CM, Lin H, Zhang Q, et al. High prevalence of left ventricular systolic and diastolic asynchrony in patients with congestive heart failure and normal QRS duration. Heart 2003; 89: 54-60. PMID: 12482792 221. Yu CM, Chan YS, Zhang Q, et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol 2006; 48: 2251-2257. PMID: 17161255 222. Chung ES, Leon AR, Tavazzi L, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation 2008; 117: 2608-2616. PMID: 18458170 223. Ruschitzka F, Abraham WT, Singh JP, et al. EchoCRT Study Group. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex. N Engl J Med 2013; 369: 1395- 1405. PMID: 23998714 224. De Pooter J, Kamoen V, El Haddad M, et al. Gender differences in electro-mechanical characteristics of left bundle branch block: Potential implications for selection and response of cardiac resynchronization therapy. Int J Cardiol 2018; 257: 84- 91. PMID: 29506744 225. Oka T, Inoue K, Tanaka K, et al. Effect of QRS morphology and duration on clinical outcomes after cardiac resynchronization therapy ― analysis of Japanese multicenter registry. Circ J 2018; 82: 1813-1821. PMID: 29628460 226. Nakai T, Mano H, Ikeya Y, et al. Narrower QRS may be enough to respond to cardiac resynchronization therapy in lightweight patients. Heart Vessels 2020; 35: 835-841. PMID: 31776736 227. Zusterzeel R, Selzman KA, Sanders WE, et al. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data. JAMA Intern Med 2014; 174: 1340-1348. PMID: 25090172 228. Cheng YJ, Zhang J, Li WJ, et al. More favorable response to cardiac resynchronization therapy in women than in men. Circ Arrhythm Electrophysiol 2014; 7: 807-815. PMID: 25146838 229. Salden OAE, van Stipdonk AMW, den Ruijter HM, et al. Heart size corrected electrical dyssynchrony and its impact on sex-specific response to cardiac resynchronization therapy. Circ Arrhythm Electrophysiol 2021; 14: e008452. PMID: 33296227 230. Steffel J, Varma N, Robertson M, et al. Effect of gender on outcomes after cardiac resynchronization therapy in patients with a narrow QRS complex: a subgroup analysis of the EchoCRT trial. Circ Arrhythm Electrophysiol 2 0 1 6 ; 9 : e 0 0 3 9 2 4 . PMID: 27282848 231. Varma N, Manne M, Nguyen D, et al. Probability and magnitude of response to cardiac resynchronization therapy according to QRS duration and gender in nonischemic cardiomyopathy and LBBB. Heart Rhythm 2014; 11: 1139-1147. PMID: 24704570 232. Varma N, Mittal S, Prillinger JB, et al. Survival in women versus men following implantation of pacemakers, defibrillators, and cardiac resynchronization therapy devices in a large, nationwide cohort. J Am Heart Assoc 2017; 6: e005031. PMID: 28490521 233. Poole JE, Singh JP, Birgersdotter-Green U. QRS duration or QRS morphology: what really matters in cardiac resynchronization therapy? J Am Coll Cardiol 2016; 67: 1104- 1117. PMID: 26940932 234. Stewart RA, Young AA, Anderson C, et al. Relationship between QRS duration and left ventricular mass and volume in patients at high cardiovascular risk. Heart 2011; 97: 1766- 1770. PMID: 21835757 235. Rickard J, Bassiouny M, Cronin EM, et al. Predictors of response to cardiac resynchronization therapy in patients with a non-left bundle branch block morphology. Am J Cardiol 2011; 108: 1576- 1580. PMID: 21890086 236. Verma A, Jiang CY, Betts TR, et al. STAR AF II Investigators. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 2015; 372: 1812-1822. PMID: 25946280 237. Vogler J, Willems S, Sultan A, et al. Pulmonary vein isolation versus defragmentation: the CHASE-AF clinical trial. J Am Coll Cardiol 2015; 66: 2743-2752. PMID: 26700836 238. Inoue K, Hikoso S, Masuda M, et al. OCVC Arrhythmia Investigators. Pulmonary vein isolation alone vs. more extensive ablation with defragmentation and linear ablation of persistent atrial fibrillation: the EARNEST-PVI trial. Europace 2021; 23: 565-574. PMID: 33200213 239. De Pooter J, Strisciuglio T, El Haddad M, et al. Pulmonary vein reconnection no longer occurs in the majority of patients after a single pulmonary vein isolation procedure. JACC Clin Electro-